FDA Inspection 1090248 - Blood Bank Of Delmarva, Inc, A Division of New York Blood Center - March 22, 2019
FDA Inspection 1090248 for Blood Bank Of Delmarva, Inc, A Division of New York Blood Center on March 22, 2019. Classification: No Action Indicated (NAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1090248 for Blood Bank Of Delmarva, Inc, A Division of New York Blood Center on March 22, 2019. Classification: No Action Indicated (NAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
March 22, 2019
Product Type
Biologics
ID: f69fa75d-3230-4b50-a8f5-1ef6b6a60b31
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox